ORIGINAL RESEARCH

The possibility of evaluation mRNA expression profiling to predict progression of local stage colorectal cancer

Goncharov SV, Bozhenko VK, Zakharenko MV, Chaptykov AA, Kulinich TM, Solodkiy VA
About authors

Russian Scientific Center for Roentgenoradiology, Moscow, Russia

Correspondence should be addressed: Sergey V. Goncharov
Profsoyuznaya, 86, 117997, Moscow, Russia; ur.liam@5109

About paper

Funding: the study was supported through the grant by RSF 22-15-00448.

Author contribution: Goncharov SV, Bozhenko VK, Solodkiy VA — study concept and design; Bozhenko VK, Goncharov SV, Kulinich TM, Zakharenko MV, Solodkiy VA — data acquisition and processing; Goncharov SV, Chaptykov AA, Bozhenko VK, Kulinich TM — manuscript writing; Goncharov SV, Chaptykov AA, Bozhenko VK, Kulinich TM, Zakharenko MV, Solodkiy VA — editing.

Received: 2023-09-13 Accepted: 2023-12-01 Published online: 2023-12-23
|
  1. Kaprin AD, Starinskij VV, Shahzadova AO. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2021 godu. Rossijskij Centr informacionnyh tehnologij i jepidemiologicheskih issledovanij v oblasti onkologii. Moskva, 2022. Russian.
  2. Steyerberg EW, Moons KGM, van der Windt DA, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS medicine. 2013; 10: e1001381.
  3. Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018; 119 (7): 785–92. DOI: 10.1038/s41416018-0264-x. Epub 2018 Oct 4. PMID: 30287914; PMCID: PMC6189126.
  4. Lin XT, Wu QN, Qin S, Fan DJ, Lv MY, Chen X, et al. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer. Front Genet. 2021; 12: 755789. DOI: 10.3389/fgene.2021.755789. PMID: 34899841; PMCID: PMC8657766.
  5. Mori K, Toiyama Y, Okugawa Y, Ichikawa T, Nagano Y, Oki S, et. al. Preoperative heat shock protein 47 levels identify colorectal cancer patients with lymph node metastasis and poor prognosis. Oncol Lett. 2020; 20 (6): 333. DOI: 10.3892/ol.2020.12196. Epub 2020 Oct 7. PMID: 33123244; PMCID: PMC7583735.
  6. Bozhenko VK, Stanojevic US, Trotsenko ID, et al. Comparison of matrix proteinase mRNA expression in morphologically normal, neoplastic, and metastatic colon tissue and colon biopsies from healthy donors. Biomed Khim. 2018; 64 (1): 46–52. DOI: 10.18097/PBMC20186401046. Russian.
  7. French CL, Ye F, Revetta F, et al. Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness. F1000Res. 2015; 4: 99. DOI: 10.12688/f1000research.6388.1.
  8. Fang Y, Yu H, Liang X, Xu J, Cai X. Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer. Cancer Biol Ther. 2014; 15 (9): 1268–79. DOI: 10.4161/cbt.29691. Epub 2014 Jun 27. PMID: 24971465; PMCID: PMC4128869.
  9. Hu B, Song X, Ding W, Wang H, Cai H, Huang Z. Expression and Clinical Significance of Ki67 and SOX2 in Colorectal Cancer. J Healthc Eng. 2023; 2023: 3783631. DOI: 10.1155/2023/3783631. PMID: 37457497; PMCID: PMC10348847.
  10. Vermehren-Schmaedick A, Mhawech-Fauceglia P, Park BS, Pejovic T, Luoh SW. The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers. Oncotarget. 2020; 11 (24): 2273–89. DOI: 10.18632/ oncotarget.27593. PMID: 32595827; PMCID: PMC7299530.
  11. Kasprzak A. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. Int J Mol Sci. 2021; 22 (12): 6434. DOI: 10.3390/ijms22126434. PMID: 34208601; PMCID: PMC8234711.
  12. Li J, Huang L, Zhao H, Yan Y, Lu J. The Role of Interleukins in Colorectal Cancer. Int J Biol Sci. 2020; 16 (13): 2323–39. DOI: 10.7150/ijbs.46651. PMID: 32760201; PMCID: PMC7378639.
  13. Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Tanaka M, Miyake O, et al. Site-specific tumor grading system in colorectal cancer: Multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol. 2014; 38: 197–204. Available from: https://doi.org/10.1097/pas.0000000000000113/
  14. Yuan H, Dong Q, Zheng BA, Hu X, Xu J-B, Tu S. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: A systematic review and meta-analysis. Oncotarget. 2017; 8: 46565–79. Available from: https://doi.org/10.18632/ oncotarget.15425.
  15. Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study. Int J Surg. 2017; 37: 42–49. Available from: https://doi.org/10.1016/j.ijsu.2016.08.528.
  16. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, et al. Lymphovascular invasion in colorectal cancer: An interobserver variability study. Am J Surg Pathol. 2008; 32: 1816.
  17. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: A review of the literature. Cancer: Inter-discip. Int J Am Cancer Soc. 2009; 115: 3379–91.
  18. (CAP) CoAP. Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum; 2020. Available online: https://documents.cap.org/protocols/ cp-gilower-colonrectum-resection-20-4100.pdf (accessed on 15 August 2021).
  19. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et.al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol Off J Am Soc Clin Oncol. 2005; 23; 8706–12. Available from: https://doi.org/10.1200/jco.2005.02.8852.
  20. Wang CY, Shao C, McDonald AC, Amonkar MM, Zhou W, Bortnichak EA, et al. Evaluation and Comparison of Real-World Databases for Conducting Research in Patients With Colorectal Cancer. JCO Clin Cancer Inform. 2023; 7: e2200184. DOI: 10.1200/CCI.22.00184. PMID: 37437227.